Indefinite Delivery Contract SPE2DB20D9332

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, awarded under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products are intended to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has received numerous delivery orders under this IDC for specialized medications such as Xolair, Kyleena, Mirena, Exparel, and Botox, among others. The delivery orders, which are not associated with any set-aside designations, allow DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. This contract position enables DMS Pharmaceutical Group to provide direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.